Trial Details

Not recruiting
Basic Information
Clinical ID c2448
Identifier NCT04769258
Trial Title Effectiveness and Safety of COVID-19 Vaccine in Patients With Inflammatory Bowel Disease Treated With Immunomodulatory or Biological Drugs
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Inflammatory Bowel Diseases
Interventions Biological: Pfizer Comirnaty vaccine
Participant Information
Sponsor Italian Group for the study of Inflammatory Bowel Disease (IG-IBD)
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement -
Study Design
Study Type Observational [Patient Registry]
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -